ZBIO
Financials
- Market Capitalization 1.77 B
- Employee 167
- Founded 2019
- CEO N/A
- Website www.zenasbio.com
- Headquarter Delaware, United States
- FIGI BBG01J1MG9D6
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2078 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 3.99 USD | -1.24% | -5.45% | -3.16% | +111.11% | 1.78 B USD | ||
| 2085 |  AAPG Ascentage Pharma Group International - American Depository Shar | 19.18 USD | -2.24% | +2.62% | +6.73% | -23.28% | 1.79 B USD | ||
| 2103 |  RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.34 USD | +1.21% | -15.01% | +1.21% | -37.10% | 1.77 B USD | ||
| 2120 |  FTRE Fortrea Holdings Inc. - Common Stock | 18.07 USD | +1.18% | +4.39% | +8.14% | +255.01% | 1.71 B USD |
Frequently asked questions about Zenas BioPharma, Inc. - Common Stock
What is the Zenas BioPharma, Inc. - Common Stock stock price today?
The current price of Zenas BioPharma, Inc. - Common Stock (ZBIO) is 27.98. Over the past 24 hours, the stock has changed by +0.36%. Follow the ZBIO chart for real-time price dynamics.
What is the stock ticker of Zenas BioPharma, Inc. - Common Stock?
Zenas BioPharma, Inc. - Common Stock trades under the ticker ZBIO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Zenas BioPharma, Inc. - Common Stock stock going up?
ZBIO has changed by +5.55% over the last week, +35.76% over the last month, and +5.74% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does Zenas BioPharma, Inc. - Common Stock release financial reports?
Yes. You can track Zenas BioPharma, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was Zenas BioPharma, Inc. - Common Stock net income for the last quarter?
Zenas BioPharma, Inc. - Common Stock reported net income of -80.99 M for the last quarter. The previous quarter showed -240.44 M, which means net income changed by +66.32%.
How many employees does Zenas BioPharma, Inc. - Common Stock have?
As of the latest available data, Zenas BioPharma, Inc. - Common Stock has 167 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy Zenas BioPharma, Inc. - Common Stock stock?
You can buy Zenas BioPharma, Inc. - Common Stock (ZBIO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Zenas BioPharma, Inc. - Common Stock stock?
Investing in Zenas BioPharma, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ZBIO chart and related analysis on metatrader.com as part of your research.